Francois M. Nortier
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Francois M. Nortier has a total of 183 co-authors. Here are the top co-authors by number of shared publications:
- Kevin D. John
Los Alamos National Laboratory, Los Alamos, NM 87545, USA
22 shared publications - Jonathan W. Engle
University of Wisconsin−Madison
21 shared publications - Michael Ernst Fassbender
Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
16 shared publications E.R. Birnbaum
Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87545, United States
11 shared publicationsA. Couture
10 shared publications- Beau Ballard
ORNL
8 shared publications
Latest Publications
- 1 November 2020
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 90-91, 69-73
A reverse 230U/226Th radionuclide generator for targeted alpha therapy applications
- 1 November 2020
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 90-91, 69-73
A reverse 230U/226Th radionuclide generator for targeted alpha therapy applications
- 1 December 2017
- Published by Elsevier in Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms
- Vol. 412, 34-40
Cross sections for proton-induced reactions on natSb up to 68 MeV
- 1 December 2017
- Published by Elsevier in Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms
- Vol. 412, 34-40
Cross sections for proton-induced reactions on natSb up to 68 MeV
- 12 January 2016
- Published by Walter de Gruyter GmbH in Radiochimica Acta
- Vol. 104 (5) , 291-304
Formation cross-sections and chromatographic separation of protactinium isotopes formed in proton-irradiated thorium metal
Targeted alpha therapy (TAT) is a treatment method of increasing interest to the clinical oncology community that utilizes α-emitting radionuclides conjugated to biomolecules for the selective killing of tumor cells. Proton irradiation of thorium generates a number of α-emitting radionuclides with therapeutic potential for application via TAT. In particular, the radionuclide 230Pa is formed via the 232Th(p, 3n) nuclear reaction and partially decays to 230U, an α emitter which has recently received attention as a possible therapy nuclide. In this study, we estimate production yields for 230Pa and other Pa isotopes from proton-irradiated thorium based on cross section measurements. We adopt existing methods for the chromatographic separation of protactinium isotopes from proton irradiated thorium matrices to combine and optimize them for effective fission product decontamination.
- 12 January 2016
- Published by Walter de Gruyter GmbH in Radiochimica Acta
- Vol. 104 (5) , 291-304
Formation cross-sections and chromatographic separation of protactinium isotopes formed in proton-irradiated thorium metal
Targeted alpha therapy (TAT) is a treatment method of increasing interest to the clinical oncology community that utilizes α-emitting radionuclides conjugated to biomolecules for the selective killing of tumor cells. Proton irradiation of thorium generates a number of α-emitting radionuclides with therapeutic potential for application via TAT. In particular, the radionuclide 230Pa is formed via the 232Th(p, 3n) nuclear reaction and partially decays to 230U, an α emitter which has recently received attention as a possible therapy nuclide. In this study, we estimate production yields for 230Pa and other Pa isotopes from proton-irradiated thorium based on cross section measurements. We adopt existing methods for the chromatographic separation of protactinium isotopes from proton irradiated thorium matrices to combine and optimize them for effective fission product decontamination.
- 11 January 2016
- Published by Springer Nature in Journal of Low Temperature Physics
- Vol. 184 (3-4) , 958-968
Development of Holmium-163 Electron-Capture Spectroscopy with Transition-Edge Sensors
- 11 January 2016
- Published by Springer Nature in Journal of Low Temperature Physics
- Vol. 184 (3-4) , 958-968
Development of Holmium-163 Electron-Capture Spectroscopy with Transition-Edge Sensors
- 1 January 2016
- Published by Elsevier in Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms
- Vol. 366, 206-216
Nuclear excitation functions from 40 to 200 MeV proton irradiation of terbium
- 1 January 2016
- Published by Elsevier in Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms
- Vol. 366, 206-216
Nuclear excitation functions from 40 to 200 MeV proton irradiation of terbium
- 1 May 2015
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 42 (5) , 428-438
Evaluation of nitrogen-rich macrocyclic ligands for the chelation of therapeutic bismuth radioisotopes
- 1 May 2015
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 42 (5) , 428-438
Evaluation of nitrogen-rich macrocyclic ligands for the chelation of therapeutic bismuth radioisotopes
- 29 April 2015
- Published by Walter de Gruyter GmbH in Radiochimica Acta
- Vol. 103 (8) , 577-585
Isolation of 163Ho from dysprosium target material by HPLC for neutrino mass measurements
The rare earth isotope 163Ho is of interest for neutrino mass measurements. This report describes the isolation of 163Ho from a proton-irradiated dysprosium target and its purification. A Dy metal target was irradiated with 16 MeV protons for 10 h. After target dissolution, 163Ho was separated from the bulk Dy via cation-exchange high performance liquid chromatography using 70 mmol dm –3 α-hydroxyisobutyric acid as the mobile phase. Subsequent purification of the collected Ho fraction was performed to remove the α-hydroxyisobutyrate chelating agent and to concentrate the Ho in a low ionic strength aqueous matrix. The final solution was characterized by MC-ICP-MS to determine the 163Ho/165Ho ratio, 163Ho and the residual Dy content. The HPLC purification process resulted in a decontamination factor 1.4E5 for Dy. The isolated Ho fraction contained 24.8 ± 1.3 ng of 163Ho corresponding to holmium recovery of 72 ± 3%.
- 29 April 2015
- Published by Walter de Gruyter GmbH in Radiochimica Acta
- Vol. 103 (8) , 577-585
Isolation of 163Ho from dysprosium target material by HPLC for neutrino mass measurements
The rare earth isotope 163Ho is of interest for neutrino mass measurements. This report describes the isolation of 163Ho from a proton-irradiated dysprosium target and its purification. A Dy metal target was irradiated with 16 MeV protons for 10 h. After target dissolution, 163Ho was separated from the bulk Dy via cation-exchange high performance liquid chromatography using 70 mmol dm –3 α-hydroxyisobutyric acid as the mobile phase. Subsequent purification of the collected Ho fraction was performed to remove the α-hydroxyisobutyrate chelating agent and to concentrate the Ho in a low ionic strength aqueous matrix. The final solution was characterized by MC-ICP-MS to determine the 163Ho/165Ho ratio, 163Ho and the residual Dy content. The HPLC purification process resulted in a decontamination factor 1.4E5 for Dy. The isolated Ho fraction contained 24.8 ± 1.3 ng of 163Ho corresponding to holmium recovery of 72 ± 3%.